Arbutus has moved into Part 3 of this clinical trial which evaluates repeat dosing of AB-101 for 28 days in patients with cHBV and expects to report preliminary data in the first half of next year.
The data from the CDC's National Immunization Survey estimates that 37.6% of Americans ages 65 and older had gotten a shot of ...
Residents should get flu and COVID-19 shots, and those who qualify should be immunized against RSV, state officials said.
As Louisiana’s rate of fully vaccinated children slips as part of blowback related to the COVID-19 pandemic, health care ...
This came despite advice from the U.S. Centers for Disease Control and Prevention (CDC) that everyone should stay up to date with COVID-19 vaccines for the person's age group to help protect against ...